ИШЕМИК ИНСУЛЬТДА ЙЎҒОН ИЧАКНИНГ МОРФОМЕТРИК КЎРСАТИЧЛАРИ АСОСИДА БАХОЛАШ МЕЗОНЛАРИ
Keywords:
иммуногистокимёвий текшириш, ишемик инсульт, ингичка ичакAbstract
БМЁҚАЎБ да йўғон ичак морфофункционал бузилишида нейроспецифик омилларни таъсириида ичаклар шиллиқ қаватида юзага келадиган ўзгаришларни морфометрик кўрсаткичларини аниқлашда, олдиндан тайёрланган микронамуналарни NanoZummer гистосканерида расмга олиб 32000 мкм2, 64000мкм2, 96000 мкм2, 128000мкм2 бир кўриш майдонидаги ўлчаиларни ўртача кўрсаткичи аниқланди. Унга кўра хар бир холатдан 2,5-5,0 мкм интервалда 10 та дан кам бўлмаган микронамуналар тиайёрланиб гистосканерда ўртача катталиклари аниқланди. Кейин ушбу 6 та холатда тайёрланган жами 60 та микронамуналарда ўрганилаётган хужайра ва бошқа компонентларини ўртача каттлаиклари олинди. Микронамунадаги текшири-лаётган сохалар аниқ бир мкм2 майдонда эгаллаган улуши ва ўлчамлари бўйича маълумотлар олинди ва махсус QuPath-0.5.0 (console)+ ImageJ PRO© дастурланган тизимbда қайта ишланди. Ушбу дастурда инсон омилисиз суъний интеллект бошқарувида амалга оширилди.
Downloads
References
1. Qamar A. A. et al. Platelet count is not a predictor of the presence or development of gastroesophageal varices in cirrhosis //Hepatology. – 2008. – Т. 47. – №. 1. – С. 153-159.
2. Reiner W., Melissa G., Markus. Pathological bacterial translocation in liver cirrhosis // Journal of Hepatology. 2014. Vol. 60. P. 197–209.
3. Salek J. et al. Recurrent liver failure in a 25‐year‐old female //Liver Transplantation. – 2010. – Т. 16. – №. 9. – С. 1049-1053.
4. Sinclair M. et al. sarcopenia in cirrhosis–aetiology, implications and potential therapeutic interventions //Alimentary pharmacology & therapeutics. – 2016. – Т. 43. – №. 7. – С. 765-777.
5. Smith T. N., De Moraes A. G., Simonetto D. A. Cirrhosis Management in the Intensive Care Unit //Seminars in Liver Disease. – Thieme Medical Publishers, Inc., 2023.
6. Stauber R. E. et al. Human nonmercaptalbumin‐2: a novel prognostic marker in chronic liver failure //Therapeutic Apheresis and Dialysis. – 2014. – Т. 18. – №. 1. – С. 74-78.
7. Tandon P. et al. A practical approach to nutritional screening and assessment in cirrhosis //Hepatology. – 2017. – Т. 65. – №. 3. – С. 1044-1057.
8. Tandon P. et al. Exercise in cirrhosis: translating evidence and experience to practice //Journal of hepatology. – 2018. – Т. 69. – №. 5. – С. 1164-1177.
9. Tsien C. D., McCullough A. J., Dasarathy S. Late evening snack: exploiting a period of anabolic opportunity in cirrhosis //Journal of gastroenterology and hepatology. – 2012. – Т. 27. – №. 3. – С. 430-441.
10. Tsukanov V. V. et al. Роль эрадикации Helicobacter pylori в профилактике рака желудка //Терапевтический архив. – 2014. – Т. 86. – №. 8. – С. 124-127.
11. Valerio C. et al. Human albumin solution for patients with cirrhosis and acute on chronic liver failure: Beyond simple volume expansion //World journal of hepatology. – 2016. – Т. 8. – №. 7. – С. 345.
12. Van Vugt J. L. A. et al. Systematic review and meta-analysis of the impact of computed tomography–assessed skeletal muscle mass on outcome in patients awaiting or undergoing liver transplantation //American Journal of Transplantation. – 2016. – Т. 16. – №. 8. – С. 2277-2292.
13. Vincent J. L., De Backer D., Wiedermann C. J. Fluid management in sepsis: The potential beneficial effects of albumin //Journal of critical care. – 2016. – Т. 35. – С. 161-167.
14. Wang D. et al. Preoperative inflammatory markers of NLR and PLR as indicators of poor prognosis in resectable HCC //PeerJ. – 2019. – Т. 7. – С. e7132.
15. Who O. Traditional Medicine. Fact Sheet. 2007. no. 134, Revised May 2003
16. World Medical Association (2013). WMA Declaration of Helsinki – Ethical principles for medical research involving human subjects. Online. Retrieved 4 July 2021, from: https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/
17. World of Work Report 2013–Repairing the economic and social fabric. – 2013. -133р.
18. Zhang M. et al. Neutrophil-to-lymphocyte ratio and albumin: new serum biomarkers to predict the prognosis of male alcoholic cirrhosis patients //BioMed Research International. – 2020. – Т. 2020. – С. 1-7.
19. Zhao Y. et al. Early sorafenib‐related adverse events predict therapy response of TACE plus sorafenib: A multicenter clinical study of 606 HCC patients //International journal of cancer. – 2016. – Т. 139. – №. 4. – С. 928-937.
